pharmaceutical-investing Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan
pharmaceutical-investing EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update